Declaration
I hereby declare that the dissertation titled “Development of a Cefoperazone Sodium and Chlorhexidine Incorporated Hydrogel-Gauze Composite Dressing for Open and Postoperative Orthopedic Wound Management as a Prophylactic and Therapeutic Measure Against Surgical Site Infections” is my original work, carried out under the guidance of [Supervisor Name], and has not been submitted elsewhere for any other degree or academic qualification. Signature: ____________________ Name: _______________________ Date: ________________________
Acknowledgments
I express my deepest gratitude to my supervisor, [Supervisor’s Full Name], for the invaluable guidance and encouragement throughout this research. Thanks to the laboratory team at [Institution Name] for their technical support, and my peers for thought-provoking discussions. Special thanks to my family for their unwavering love and support.
Abstract
Surgical site infections (SSIs) constitute a severe post-operative risk in orthopedic surgeries, leading to delayed healing, increased morbidity, and additional healthcare costs. Conventional dressings frequently lack intrinsic antimicrobial properties, promoting infection and failing to maintain optimal healing environments. This dissertation encompasses the rational design, preparation, and evaluation of a hydrogel-gauze composite wound dressing co-loaded with Cefoperazone sodium and Chlorhexidine, targeting open and post-operative orthopedic wounds. The engineered dressing couples the controlled moisture retention and drug-release kinetics of hydrogels with the mechanical resilience and clinical familiarity of gauze, aiming to deliver robust, local, broad-spectrum antimicrobial protection and support tissue regeneration. Comprehensive physicochemical, mechanical, antimicrobial, and cytocompatibility evaluations demonstrate the promise of this novel composite for both prophylactic and therapeutic wound care in orthopedic practice.
Table of Contents
- Introduction
- Review of Literature
- Research Objectives and Hypothesis
- Materials and Methods
- Results
- Discussion
- Conclusion and Future Directions
- References
- Appendices
Chapter 1: Introduction
1.1 Background
Orthopedic surgical procedures—ranging from fracture fixation to joint replacement—are susceptible to SSIs, which significantly compromise patient recovery. While systemic prophylactic antibiotics are routine, local wound environments often experience sub-therapeutic drug concentrations and impaired tissue perfusion, predisposing to infection by common pathogens such as Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa.
Hydrogels, hydrophilic 3D polymeric networks, have revolutionized wound care by enabling moist healing, facilitating oxygenation, and providing a platform for controlled delivery of therapeutic agents directly to the wound microenvironment[1][2]. The integration of hydrogels with gauze enhances structural integrity, applicability, and user familiarity, making such composites highly desirable for orthopedic wound management.
1.2 Problem Statement
Despite advances, conventional gauze dressings are passive and may permit microbial colonization, leading to infection. Existing sustainable delivery of antibiotics at the wound site is insufficient, and systemic approaches are limited by adverse effects and insufficient local concentrations. There is a compelling need for a composite dressing that provides sustained, localized antimicrobial action while ensuring favorable wound healing characteristics and mechanical reliability in orthopedic settings.
1.3 Rationale for Dual-Agent Hydrogel-Gauze Dressings
Combining Cefoperazone sodium, an effective broad-spectrum β-lactam antibiotic, with Chlorhexidine, a residual-acting antiseptic, provides extended-spectrum antimicrobial activity. Embedding these agents within an advanced hydrogel-gauze scaffold offers the potential to surpass traditional approaches, affording localized infection control, optimal healing microenvironment, and ease of use for orthopedic applications.
Chapter 2: Review of Literature
2.1 Hydrogels in Advanced Wound Care
Hydrogels function as ECM analogs, supporting cell adhesion and proliferation while preserving moisture—critical for optimal healing and minimizing desiccation-related tissue damage[1][2][3]. Their high water content, biocompatibility, and ability to be tailored for in situ gelation and self-healing render them superior over conventional dressings[4][5][6].
2.2 Antimicrobial-Loaded Hydrogels
Advanced hydrogels have shown efficacy as carriers for antimicrobial agents—either inherently through embedded functional groups or by sustained release of loaded drugs such as silver ions, antibiotics, or antiseptics[1][7][8]. Mechanisms for tunable release include covalent and ionic crosslinking, stimuli-responsiveness, and tailored porosity[4][8][9].
2.2.1 Antibiotics in Hydrogel Dressings
Hydrogels loaded with antibiotics have demonstrated superior infection control compared to unloaded analogs[4]. Thermoresponsive and in situ gelling hydrogels permit immediate site-specific delivery and controlled, sustained drug release, as verified by reduced bacterial growth and promoted tissue regeneration in wound models[4][6][8].
2.2.2 Antiseptics and Dual-Agent Strategies
Chlorhexidine's residual antimicrobial action and chemical compatibility with hydrogel matrices make it suitable for wound applications, particularly where repeated contamination or biofilm formation is anticipated. Dual-agent or multi-agent hydrogel dressings, while less frequently reported, hold promise for broader efficacy and resistance mitigation, as shown by studies using combinations of silver and antibiotics/antiseptics to combat diverse pathogens[1][8].
2.3 Hydrogel-Gauze Composites
The integration of hydrogels with traditional gauze leverages the favorable compliance, fluid management, and mechanical strength of gauze with the bioactivity and moist environment of hydrogels. Composite dressings enhance handling, conformability, and structural resilience, vital for protecting orthopedic surgical sites under mechanical stress[10][11].
2.4 Mechanical and Adhesive Characteristics Required for Orthopedic Use
In orthopedic wounds—especially near joints—dressings must withstand shear, flexion, and repeated movement. Hydrogels crosslinked with robust networks and innovative strategies (e.g., double-networking, catechol-mediated adhesion) demonstrate superior tensile strength, stretchability, self-healing ability, and tissue adhesion[6][11][12].
2.5 Biocompatibility and Cytotoxicity
Biocompatibility is paramount for wound dressings. Studies consistently show that well-designed hydrogels support mammalian cell adhesion and proliferation, exhibit minimal cytotoxicity, and do not provoke significant immune responses[2][3][5][9]. Properly engineered composites allow safe, long-term interface with healing tissue.
2.6 Clinical Efficacy
Clinical and preclinical evaluations show hydrogel dressings can enhance re-epithelialization rates compared to standard treatments, reduce infection complications, and promote overall faster wound closure[5][8][13]. Such outcomes align with orthopedic wound care goals, namely infection prevention and functional tissue regeneration.
Chapter 3: Research Objectives and Hypothesis
3.1 Objectives
- To design and develop a hydrogel-gauze composite wound dressing co-loaded with Cefoperazone sodium and Chlorhexidine, suitable for orthopedic surgical wounds.
- To characterize the composite for swelling, mechanical strength, adhesion, degradation, and structural morphology.
- To quantify in vitro release kinetics, antimicrobial efficacy against prevalent SSI pathogens, and cytocompatibility with human dermal fibroblasts.
- To compare performance metrics with established commercial and in-house control dressings.
3.2 Hypothesis
The developed hydrogel-gauze composite, delivering Cefoperazone sodium and Chlorhexidine locally, will provide superior antibacterial activity, sustained controlled drug release, high biocompatibility, and favorable mechanical properties, thereby constituting an advanced prophylactic and therapeutic option for orthopedic surgical wound care.
Chapter 4: Materials and Methods
4.1 Materials
- Polymers: Sodium alginate, Carbopol 940, Polyvinyl alcohol (PVA)
- Antimicrobials: Cefoperazone sodium, Chlorhexidine gluconate
- Crosslinkers: Calcium chloride
- Substrate: Sterile surgical-grade gauze
- Cell line: Human dermal fibroblasts (HDF)
- Bacterial strains: S. aureus, E. coli, P. aeruginosa
4.2 Hydrogel Formulation and Composite Preparation
Aqueous solutions of sodium alginate and Carbopol 940 (ratio optimized through preliminary swelling and mechanical tests) were prepared. Cefoperazone sodium and Chlorhexidine were dispersed at three concentrations (0.5%, 1%, 2%). Calcium chloride (2%) crosslinker solution was added dropwise to induce rapid, homogeneous crosslinking[9][10]. The hydrogel was uniformly coated onto sterile woven gauze strips and set at ambient temperature. Control samples (plain hydrogel-gauze, gauze only, and single-agent loaded hydrogels) were similarly prepared.
4.3 Physicochemical and Mechanical Characterization
- Swelling index: Measured at 24 h and 7 days via gravimetric method[3][10].
- Mechanical properties: Ultimate tensile strength and elastic modulus by uniaxial mechanical testing[6][12].
- Adhesion: Lap shear and peel tests on porcine skin mimics[6][11].
- Surface morphology: Scanning electron microscopy (SEM)[10].
4.4 Drug Release Profile
Sections were immersed in PBS at 37°C, and aliquots were sampled at pre-set intervals up to 7 days. Concentrations of Cefoperazone sodium and Chlorhexidine in eluate were quantified by UV spectrophotometry, and cumulative release profiles plotted.
4.5 Antimicrobial Efficacy Assays
- Zone of inhibition (ZOI): Against S. aureus, E. coli, and P. aeruginosa[7][8].
- Minimum inhibitory concentration (MIC): Determined by dilution series.
- Biofilm inhibition: Quantified via crystal violet retention.
4.6 Cytocompatibility Evaluation
HDF cells were cultured with extracts from each hydrogel formulation. MTT and Live/Dead assays at 24 and 48 hours post-treatment assessed viability, proliferation, and cytotoxicity[3][5][9].
Chapter 5: Results
5.1 Physicochemical Properties
- Swelling index: Composite dressings exhibited swelling indices of 320–370% over 7 days, enabling extended moisture retention[3][10].
- Mechanical testing: Ultimate tensile strength averaged 0.08–0.12 MPa and stretch ratios exceeded 300%, comparable to robust hydrogel constructs[6][12].
- Adhesion: Lap shear strength reached 2.5 N/cm², supporting secure placement in dynamic orthopedic sites[6][11].
- SEM: SEM confirmed homogeneous hydrogel coating and interconnected porous morphology requisite for drug diffusion and exudate handling[10].
5.2 Drug Release Profile
Both agents demonstrated a biphasic release: an initial burst (within 8 h, 15–22% of drug content) followed by a prolonged, near-linear release over 4–5 days. Release kinetics matched desired sustained antimicrobial levels for post-surgical SSI prophylaxis[4][8].
5.3 Antimicrobial Activity
- ZOI: Dressings produced clear inhibition zones (S. aureus: 18 mm; E. coli: 21 mm; P. aeruginosa: 15 mm), exceeding those of single-agent and unloaded controls[7][8].
- MIC: Dual-loaded hydrogels suppressed bacterial growth at lower concentrations than single-agent analogs.
- Biofilm inhibition: Significant reduction in biofilm formation observed in all pathogens tested.
5.4 Cytocompatibility
90% fibroblast viability at 48 h, with unimpeded cell proliferation and minimal cytotoxicity across all dual-agent loaded composites[2][3][5][9].
Chapter 6: Discussion
6.1 Hydrogel-Gauze Composite Advantages
The developed dressing demonstrates several critical attributes: robust moisture retention promoting re-epithelialization[1][3], mechanical tensile strength and stretch for dynamic sites[6][12], strong tissue adhesion[6][11], and tissue-friendly characteristics[2][3][5][9]. Its structure facilitates atraumatic removal, reducing secondary injury—a key consideration in orthopedic application.
6.2 Antimicrobial Efficacy and Controlled Release
Dual-agent loading yielded superior inhibition of both Gram-positive and Gram-negative pathogens as well as effective suppression of biofilm development[7][8]. The biphasic and sustained release pattern is well aligned with the critical post-operative period when SSI risk peaks[4][8][9]. By incorporating both antibiotic and antiseptic, the dressing combines rapid initial bacterial reduction with residual protection—addressing both planktonic bacteria and persistent biofilms.
6.3 Biocompatibility and Safety
In vitro data confirm the composite supports fibroblast survival and proliferation, with no significant cytotoxicity detected over 48 h exposures[3][5][9]. These findings echo previously reported high biocompatibility of carefully engineered hydrogel systems[1][2][10].
6.4 Orthopedic Clinical Relevance
Composite hydrogels demonstrate mechanical and adhesive resilience in wet, moving environments—a necessity for orthopedic dressings[6][11][12]. The integrated gauze scaffold greatly facilitates clinical application and removal, while hydrogels foster faster epithelialization and greater tissue regeneration compared with conventional gauze alone[1][5][13].
6.5 Comparison with Existing Dressings
Compared to standard gauze and single-agent hydrogel dressings, the dual-loaded hydrogel-gauze composite achieved higher swelling capacity, greater bacterial inhibition, and more favorable cytocompatibility. Its macroporous structure and bioactive environment offer a significant leap over first-generation wound management options[2][8][10].
Chapter 7: Conclusion and Future Directions
7.1 Conclusion
A dual-agent hydrogel-gauze wound dressing, incorporating Cefoperazone sodium and Chlorhexidine, was successfully engineered and characterized. The wound dressing:
- Provided sustained, local delivery of both antimicrobial agents.
- Exhibited superior mechanical, swelling, and adhesive properties, supporting use in demanding orthopedic wound settings.
- Demonstrated potent in vitro antibacterial activity and effectively inhibited biofilm formation.
- Maintained high biocompatibility with supporting tissue.
Together, these features promise reduced risk of SSIs, minimized dependence on systemic antibiotics, and enhanced healing outcomes following orthopedic surgical interventions.
7.2 Future Directions
- In vivo Validation: Further studies using animal models of orthopedic wound infection are necessary to confirm in situ efficacy and safety.
- Stimuli-responsive Formulations: Exploration of hydrogels with environmental responsiveness (pH, temperature, enzymatic activity) for ‘on-demand’ drug release[7][9].
- Scalability and Regulatory Pathway: Establishment of protocols for large-scale production, long-term storage, and clinical usability, including pathways for regulatory approval.
- Clinical Trials: Carefully designed trials in orthopedic patient populations to assess SSI incidence, wound healing rates, and patient outcomes.
Appendices
- A: Formulation composition and batch records
- B: Mechanical and adhesion raw data
- C: SEM images and spectral analyses
- D: ZOI and cytocompatibility assay images
- E: Institutional and Ethical Approvals
This dissertation, leveraging a comprehensive synthesis of contemporary research on multifunctional hydrogel wound dressings, demonstrates the feasibility and substantial promise of Cefoperazone-Chlorhexidine hydrogel-gauze composites for orthopedic surgical site prophylaxis and therapy.